FINAL PROGRAM - Society for Immunotherapy of Cancer

Poster Listings
62
DETECTION OF ANTIGEN-STIMULATED
CYTOKINE-SECRETION INT-CELLS AT SINGLE CELL
LEVELS ON A LIVE CELL CHIP
Hiroyuki Kishi 1 , Eiji Kobayashi 1 , Tatsuhiko Ozawa 1 , Hiroshi Hamana 1 ,
Terumi Nagai 1 , Kazuto Tajiri 2 , Atsushi Muraguchi 1
1
Department of Immunology, Graduate School of Medicine and
Pharmaceutical Sciences, University of Toyama, Toyama, Japan
2
Department of the Third Internal Medicine, Graduate School of
Medicine and Pharmaceutical Sciences, University of Toyama, Toyama,
Japan
63
DIRECTTCR EXPRESSION ASSAY (DTEA) FOR
QUANTIFYINGT-CELL RECEPTOR -CHAIN
AND -CHAIN DIVERSITY USINGTHE DIGITAL
NCOUNTER ASSAY SYSTEM AND ITS
IMPLICATIONS IN ADOPTIVET CELLTHERAPY
Sourindra Maiti 1 , Minying Zhang 2 , Chantale Bernatchez 2 , Hiroki
Torikai 1 , Helen Huls 1 , Dean A. Lee 1 , Patrick Hwu 2 , Laszlo Radvanyi 2 ,
Laurence J. Cooper 1
1
Pediatrics, MD Anderson Cancer Center, Houston, TX
2
Melanoma Medical Oncology, MD Anderson Cancer Center, Houston,
TX
64
PREDICTION OF CANCER IMMUNOTHERAPY
RESPONDERS BY QUANTIFYING EX VIVO INDUCED
MESSENGER RNAs IN WHOLE BLOOD
Masato Mitsuhashi 1 , Yoichi Kato 2
1
Hitachi Chemical Research Center, Inc., Irvine, CA
2
Shin-Yokohama Kato Clinic, Yokohama, Japan
65
EVALUATION OF ISOTOPIC AND NON-ISOTOPIC
TECHNOLOGIES FOR ASSESSING POTENCY OF
CHIMERIC FUSION IMMUNOTOXINS CONSISTING
OF IL-13 OR IL-4 AND TRUNCATED PSEUDOMONAS
EXOTOXIN IN RECEPTOR POSITIVE HUMAN
CANCER CELLS
Prabhudas S. Patel, Pamela Leland, Raj K. Puri, Bharat H. Joshi
Division of Cellular and Gene Therapies, CBER, U.S. Food and Drug
Administration, Bethesda, MD
66
MODULATION OF IMMUNE CELL
SUBPOPULATIONS IN RENAL CELL CARCINOMA
PATIENTS BY SUNITINIB
Barbara Seliger 1 , Corinna Giersberg 1 , Michael Staehler 2
1
Martin Luther University, Institute of Medical Immunology, Halle,
Germany
2
Technical University, Department of Urology, Munich, Germany
67
CHANGES IN ICOS+ AND ICOS- POPULATIONS OF
MEMORY AND REGULATORYT CELLS IN STAGE IV
MELANOMA PATIENTS UNDERGOING ANTI-CTLA4
THERAPY
Janet C. Siebert 1 , Edwin B. Walker 2 , Brendan D. Curti 2 , Walter J.
Urba 2
1
CytoAnalytics, Denver, CO
2
Robert W. Franz Cancer Research Center, Earle A. Chiles Research
Institute, Providence Portland Medical Center, Portland, OR
68
A NOVEL COLORECTAL CANCER VACCINE
CONSISTING OF MULTIPLE NATURALLY
PRESENTED PEPTIDES
Steffen Walter 1 , Sabrina Kuttruff 1 , Andrea Mayer 1 , Oliver Schoor 1 ,
Joerg Ludwig 1 , Frank Mayer 2 , Erika Hitre 3 , Bernhard Roessler 1 ,
Dominik Maurer 1 , Verona Vass 1 , Juha Lindner 1 , Nina Pawlowski 1 ,
Claudia Trautwein 1 , Joern Dengjel 1 , Norbert Hilf 1 , Toni Weinschenk 1 ,
Juergen Frisch 1 , Carsten Reinhardt 1 , Harpreet Singh-Jasuja 1
1
Immatics Biotechnologies, Tuebingen, Germany
2
University of Tuebingen, Tuebingen, Germany
3
National Institute of Oncology, Budapest, Hungary
69
THE GENETICS DRIVINGTH1 VSTH17 IMMUNE
RESPONSES; A COMPARATIVE ANALYSIS OF
MELANOMA METASTASES AND DESCENDENT
CELL LINES
Tara L. Spivey 1 , Valeria De Giorgi 1 , Yingdong Zhao 2 , Davide
Bedognetti 1 , Zoltan Pos 3 , Quizhen Lui 1 , Sara Tomei 1 , Maria Libera
Ascierto 1 , Lorenzo Uccellini 1 , Ena Wang 1 , Francesco M. Marincola 1
1
Department of Transfusion Medicine, National Institutes of Health,
Bethesda, MD
2
Biometric Research Branch, Division of Cancer Treatment and
Diagnosis, National Institutes of Health, Bethesda, MD
3
Department of Genetics, Cell- and Immunobiology, Semmelweis
University, Budapest, Hungary
70
IN VIVO IMAGING FOR ASSESSING
BIODISTRIBUTION OF IL-13PE IMMUNOTOXIN IN A
MOUSE MODEL OF GLIOBLASTOMA
Akiko Suzuki 1 , Pamela Leland 1 , Hisataka Kobayashi 2 , Peter Choyke 2 ,
Tomio Inoue 3 , Bharat H. Joshi 1 , Raj K. Puri 1
1
Center for Biologics Evaluation and Research, FDA, Bethesda, MD
2
National Cancer Institute, NIH, Bethesda, MD
3
Radiology, Yokohama City University, Yokohama, Japan
64
FINAL PROGRAM • SITC 26 TH ANNUAL MEETING
November 4-6, 2011 • North Bethesda, MD • www.sitcancer.org